TRCT
DOC icon

Tower Research Capital (TRC)’s Healthpeak Properties DOC Stock Holding History

Tower Research Capital (TRC)’s Portfolio DOC Stock Details DOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$713K Buy
43,384
+28,002
+182% +$480K 0.02% 700
2025
Q4 		$247K Sell
15,382
-3,841
-20% -$67.7K 0.01% 1274
2025
Q3 		$368K Sell
19,223
-5,823
-23% -$104K 0.01% 1053
2025
Q2 		$439K Sell
25,046
-29,874
-54% -$531K 0.01% 1092
2025
Q1 		$1.11M Buy
54,920
+13,895
+34% +$281K 0.03% 464
2024
Q4 		$832K Buy
41,025
+2,671
+7% +$57.9K 0.02% 727
2024
Q3 		$877K Sell
38,354
-4,616
-11% -$99.5K 0.02% 594
2024
Q2 		$842K Buy
42,970
+2,974
+7% +$56.8K 0.01% 901
2024
Q1 		$750K Sell
39,996
-29,369
-42% -$534K 0.02% 638
2023
Q4 		$1.37M Buy
69,365
+43,048
+164% +$757K 0.02% 663
2023
Q3 		$483K Buy
26,317
+4,908
+23% +$101K 0.02% 888
2023
Q2 		$430K Sell
21,409
-25,116
-54% -$521K 0.01% 1074
2023
Q1 		$1.02M Buy
46,525
+31,097
+202% +$771K 0.03% 433
2022
Q4 		$386K Sell
15,428
-15,941
-51% -$387K 0.02% 856
2022
Q3 		$719K Sell
31,369
-10,834
-26% -$286K 0.01% 873
2022
Q2 		$1.09M Sell
42,203
-79,457
-65% -$2.41M 0.02% 638
2022
Q1 		$4.18M Buy
121,660
+50,334
+71% +$1.7M 0.04% 359
2021
Q4 		$2.57M Buy
71,326
+27,647
+63% +$953K 0.04% 339
2021
Q3 		$1.46M Buy
43,679
+3,078
+8% +$109K 0.04% 353
2021
Q2 		$1.35M Sell
40,601
-40,153
-50% -$1.35M 0.04% 465
2021
Q1 		$2.56M Buy
80,754
+44,497
+123% +$1.35M 0.04% 396
2020
Q4 		$1.1M Buy
36,257
+5,727
+19% +$167K 0.03% 473
2020
Q3 		$829K Buy
30,530
+19,935
+188% +$546K 0.01% 1162
2020
Q2 		$292K Buy
10,595
+9,415
+798% +$240K 0.01% 1467
2020
Q1 		$28K Buy
1,180
+1,120
+1,867% +$36.5K ﹤0.01% 1543
2019
Q4 		$2K Sell
60
-9,811
-99% -$343K ﹤0.01% 3034
2019
Q3 		$352K Buy
9,871
+8,565
+656% +$289K 0.02% 731
2019
Q2 		$42K Sell
1,306
-16,621
-93% -$517K ﹤0.01% 1695
2019
Q1 		$561K Buy
+17,927
New +$546K 0.03% 528
2018
Q4 		– Sell
-999
Closed -$26K – 3903
2018
Q3 		$26K Sell
999
-22,440
-96% -$590K ﹤0.01% 2167
2018
Q2 		$605K Buy
+23,439
New +$553K 0.03% 550
2018
Q1 		– Sell
-76
Closed -$2K – 3369
2017
Q4 		$2K Sell
76
-887
-92% -$23.5K ﹤0.01% 3187
2017
Q3 		$27K Sell
963
-583
-38% -$17.5K ﹤0.01% 2520
2017
Q2 		$50K Buy
1,546
+1,215
+367% +$38.5K 0.01% 747
2017
Q1 		$10K Sell
331
-21,822
-99% -$670K ﹤0.01% 1760
2016
Q4 		$658K Buy
22,153
+17,669
+394% +$539K 0.07% 291
2016
Q3 		$155K Buy
4,484
+4,345
+3,126% +$152K 0.02% 604
2016
Q2 		$4K Sell
139
-1,591
-92% -$49.4K ﹤0.01% 3509
2016
Q1 		$51K Sell
1,730
-18,664
-92% -$560K 0.01% 765
2015
Q4 		$710K Buy
20,394
+19,496
+2,171% +$652K 0.12% 101
2015
Q3 		$30K Sell
898
-628
-41% -$21.7K ﹤0.01% 1388
2015
Q2 		$51K Sell
1,526
-723
-32% -$26.3K ﹤0.01% 1346
2015
Q1 		$88K Sell
2,249
-2,771
-55% -$111K 0.01% 998
2014
Q4 		$201K Sell
5,020
-8,244
-62% -$327K 0.02% 309
2014
Q3 		$480K Buy
13,264
+13,227
+35,749% +$502K 0.05% 268
2014
Q2 		$1K Buy
+37
New +$1.39K ﹤0.01% 3643
2014
Q1 		– Sell
-14,169
Closed -$468K – 4533
2013
Q4 		$468K Buy
14,169
+14,059
+12,781% +$501K 0.08% 200
2013
Q3 		$4K Sell
110
-398
-78% -$15.5K ﹤0.01% 3782
2013
Q2 		$21K Buy
+508
New +$23.2K ﹤0.01% 1657

Other funds holding DOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Tower Research Capital (TRC)'s DOC Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Healthpeak Properties (DOC) stake by 182% in Q1 2026, buying an estimated $480K and bringing the position to 43,384 shares worth $713K. The position accounts for 0.02% of the portfolio, ranked #700.

Tower Research Capital (TRC) first reported a position in DOC in Q2 2013 and has held it in 49 quarters since. The position peaked at $4.18M in Q1 2022. 756 funds tracked by Wall St. Rank hold DOC as of Q1 2026.

  • Tower Research Capital (TRC) held 43,384 shares of Healthpeak Properties worth $713K as of Q1 2026.
  • Tower Research Capital (TRC) bought 28,002 Healthpeak Properties shares in Q1 2026, an estimated $480K.
  • Healthpeak Properties made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #700 holding.
  • Tower Research Capital (TRC) first reported a position in Healthpeak Properties in Q2 2013 and has held it in 49 quarters since.
  • Tower Research Capital (TRC)'s Healthpeak Properties position peaked at $4.18M in Q1 2022.
  • 756 funds tracked by Wall St. Rank held Healthpeak Properties as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.